...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma
【24h】

DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma

机译:表达DC-SIGN的巨噬细胞触发滤泡性淋巴瘤中甘露糖基化IgM B细胞受体的激活

获取原文
获取原文并翻译 | 示例

摘要

Follicular lymphoma (FL) results from the accumulation of malignant germinal center (GC) B cells leading to the development of an indolent and largely incurable disease. FL cells remain highly dependent on B-cell receptor (BCR) signaling and on a specific cell microenvironment, including T cells, macrophages, and stromal cells. Importantly, FL BCR is characterized by a selective pressure to retain surface immunoglobulin M(IgM) BCR despite an active class-switch recombination process, and by the introduction, in BCR variable regions, of N-glycosylation acceptor sites harboring unusual high-mannose oligosaccharides. However, the relevance of these 2 FL BCR features for lymphomagenesis remains unclear. In this study, we demonstrated that IgM(+) FL B cells activated a stronger BCR signaling network than IgG(+) FL B cells and normal GC B cells. BCR expression level and phosphatase activity could both contribute to such heterogeneity. Moreover, we underlined that a subset of IgM(+) FL samples, displaying highly mannosylated BCR, efficiently bound dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), which could in turn trigger delayed but long-lasting BCR aggregation and activation. Interestingly, DC-SIGN was found within the FL cell niche in situ. Finally, M2 macrophages induced a DC-SIGN-dependent adhesion of highly mannosylated IgM(+) FL B cells and triggered BCR-associated kinase activation. Interestingly, pharmacologic BCR inhibitors abolished such crosstalk between macrophages and FL B cells. Altogether, our data support an important role for DC-SIGN-expressing infiltrating cells in the biology of FL and suggest that they could represent interesting therapeutic targets.
机译:滤泡性淋巴瘤(FL)是由恶性生发中心(GC)B细胞的积累导致的,导致发展为惰性和很大程度上无法治愈的疾病。 FL细胞仍然高度依赖B细胞受体(BCR)信号传导和特定的细胞微环境,包括T细胞,巨噬细胞和基质细胞。重要的是,FL BCR的特征是尽管有一个活跃的类别转换重组过程,但仍能选择性地保留表面免疫球蛋白M(IgM)BCR,并在BCR可变区引入N-糖基化受体位点,该位点含有不寻常的高甘露糖寡糖。然而,这两个FL BCR功能与淋巴瘤发生的相关性仍不清楚。在这项研究中,我们证明了IgM(+)FL B细胞比IgG(+)FL B细胞和正常GC B细胞激活了更强的BCR信号网络。 BCR表达水平和磷酸酶活性都可能导致这种异质性。此外,我们强调了显示高甘露糖基化BCR的IgM(+)FL样品的一个子集,有效结合了树突状细胞特异性细胞间粘附分子3-整合素(DC-SIGN),这反过来又可能触发延迟但持久的BCR聚合和激活。有趣的是,在FL细胞壁垒中原位发现了DC-SIGN。最后,M2巨噬细胞诱导高度甘露糖基化的IgM(+)FL B细胞的DC-SIGN依赖性粘附并触发BCR相关的激酶激活。有趣的是,药理BCR抑制剂消除了巨噬细胞和FL B细胞之间的这种串扰。总之,我们的数据支持表达DC-SIGN的浸润细胞在FL生物学中的重要作用,并暗示它们可以代表有趣的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号